Cellyrix Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.41M

  • Investors
  • 6

Cellyrix Therapeutics General Information

Description

Operator of a biotechnology company intended to introduce a new modality into cancer treatment. The company helps in treatment challenges such as therapy resistance, metastasis, and relapse, enabling cancer patients to get quality treatment via single-cell sequencing and artificial intelligence.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rehovot
  • Israel
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • Rehovot
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellyrix Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 30-Sep-2025 $1.41M Completed Startup
To view Cellyrix Therapeutics’s complete valuation and funding history, request access »

Cellyrix Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preferred Shares
Preferred Shares
To view Cellyrix Therapeutics’s complete cap table history, request access »

Cellyrix Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellyrix Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
AION Labs Accelerator/Incubator Minority
Amiti Ventures Venture Capital Minority
AstraZeneca Corporation Minority
Israel Biotech Fund Venture Capital Minority
Teva Pharmaceutical Industries Corporation Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Cellyrix Therapeutics FAQs

  • When was Cellyrix Therapeutics founded?

    Cellyrix Therapeutics was founded in 2024.

  • Where is Cellyrix Therapeutics headquartered?

    Cellyrix Therapeutics is headquartered in Rehovot, Israel.

  • What is the size of Cellyrix Therapeutics?

    Cellyrix Therapeutics has 7 total employees.

  • What industry is Cellyrix Therapeutics in?

    Cellyrix Therapeutics’s primary industry is Discovery Tools (Healthcare).

  • Is Cellyrix Therapeutics a private or public company?

    Cellyrix Therapeutics is a Private company.

  • What is the current valuation of Cellyrix Therapeutics?

    The current valuation of Cellyrix Therapeutics is .

  • What is Cellyrix Therapeutics’s current revenue?

    The current revenue for Cellyrix Therapeutics is .

  • How much funding has Cellyrix Therapeutics raised over time?

    Cellyrix Therapeutics has raised $1.41M.

  • Who are Cellyrix Therapeutics’s investors?

    AION Labs, Amiti Ventures, AstraZeneca, Israel Biotech Fund, and Teva Pharmaceutical Industries are 5 of 6 investors who have invested in Cellyrix Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process